Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines.
Saved in:
| Title: | Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines. |
|---|---|
| Authors: | Soleiman M; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Fathi-Roudsari M; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Khajeh K; Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran., Maghsoudi A; Atra Zist Aray, Tehran, Iran. |
| Source: | Cancer investigation [Cancer Invest] 2024 Apr; Vol. 42 (4), pp. 319-332. Date of Electronic Publication: 2024 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38695671 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Soleiman+M%22">Soleiman M</searchLink>; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Fathi-Roudsari+M%22">Fathi-Roudsari M</searchLink>; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Khajeh+K%22">Khajeh K</searchLink>; Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Maghsoudi+A%22">Maghsoudi A</searchLink>; Atra Zist Aray, Tehran, Iran. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228307154%22">Cancer investigation</searchLink> [Cancer Invest] 2024 Apr; Vol. 42 (4), pp. 319-332. <i>Date of Electronic Publication: </i>2024 May 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8307154 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-4192 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207357907%22">07357907 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38695671 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/07357907.2024.2345183 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 319 Titles: – TitleFull: Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Soleiman M – PersonEntity: Name: NameFull: Fathi-Roudsari M – PersonEntity: Name: NameFull: Khajeh K – PersonEntity: Name: NameFull: Maghsoudi A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1532-4192 Numbering: – Type: volume Value: 42 – Type: issue Value: 4 Titles: – TitleFull: Cancer investigation Type: main |
| ResultId | 1 |
